Other than the upregulation of GLT-1 expression, the attenuation of neuroinflammation and of oxidative stress, as well as providing neuroprotection for various neurodegenerative diseases we find it useful in animal models of AD, PD and ALS [56,57,58]. Here, SLC1A2 is linked to amyotrophic lateral sclerosis.